Prof. Myśliwiec elected again to be the member of the Board of the Polish Society of Diabetology for the term 2019-2023.
2019-05-25
May 2019
See other news
2025-06-13
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
2025-04-23
PolTREG accelerates the development of next-generation antigen-specific Tregtherapy for Type 1 Diabetes
2025-03-27
PolTREG partners with Noble Capital Markets Inc. to prepare for potential fundraising in the U.S.
2025-03-25
Webinar: PolTREG’s Strategic Collaboration with Antion Biosciences and Growth Prospects for 2025